We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$426M
AUM Growth
-$51.7M
Cap. Flow
-$20.6M
Cap. Flow %
-4.84%
Top 10 Hldgs %
29.07%
Holding
112
New
8
Increased
28
Reduced
43
Closed
13

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$11.4M
2
CCI icon
Crown Castle
CCI
+$5.45M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.4M
4
FTNT icon
Fortinet
FTNT
+$5.12M
5
SBUX icon
Starbucks
SBUX
+$4.84M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$9.01M
2
AAPL icon
Apple
AAPL
+$8.76M
3
SIAL
SIGMA - ALDRICH CORP
SIAL
+$6.44M
4
QRVO icon
Qorvo
QRVO
+$5.01M
5
NXPI icon
NXP Semiconductors
NXPI
+$4.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.36%
2 Consumer Discretionary 18.93%
3 Technology 18.76%
4 Industrials 8.65%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
101
Allstate
ALL
$65.5B
-40,900
Closed -$2.65M
BIIB icon
102
Biogen
BIIB
$29.6B
-22,315
Closed -$9.01M
BWA icon
103
BorgWarner
BWA
$13.2B
-87,131
Closed -$4.36M
CSX icon
104
CSX Corp
CSX
$97.8B
-312,600
Closed -$3.4M
EXAS
105
DELISTED
Exact Sciences
EXAS
-8,000
Closed -$237K
PPG icon
106
PPG Industries
PPG
$25.4B
-29,200
Closed -$3.35M
QRVO icon
107
Qorvo
QRVO
$7.65B
-62,383
Closed -$5.01M
SLAB icon
108
Silicon Laboratories
SLAB
$7.15B
-54,800
Closed -$2.96M
STX icon
109
Seagate
STX
$207B
-13,900
Closed -$660K
VEEV icon
110
Veeva Systems
VEEV
$29.2B
-66,000
Closed -$1.85M
PRFT
111
DELISTED
Perficient Inc
PRFT
-24,300
Closed -$467K
NBSE
112
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-33
Closed -$32K

Similar funds

De Burlo Group's Q3 2015 Portfolio in Review

As of Q3 2015, De Burlo Group held 112 positions worth $426M, down 11% from $478M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

De Burlo Group withdrew a net $20.6M in Q3 2015, closing 13 positions and reducing 43 holdings. Its most notable exit was Biogen, an estimated $9.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, De Burlo Group opened a new position in Allergan plc worth $10.1M.

  • De Burlo Group's largest Q3 2015 buy was Allergan plc: 37,185 shares worth $10.1M.
  • De Burlo Group added most to Starbucks in Q3 2015, an estimated $4.84M increase.
  • De Burlo Group's biggest Q3 2015 reduction was Apple, cutting an estimated $8.76M.
  • De Burlo Group fully exited Biogen in Q3 2015, selling an estimated $9.01M.
  • De Burlo Group's ten largest holdings make up 29% of its $426M portfolio in Q3 2015.
  • De Burlo Group opened 8 new positions and closed 13 in Q3 2015.
  • De Burlo Group's portfolio value fell 11% quarter-over-quarter to $426M.

Based on De Burlo Group's 13F filing for Q3 2015, filed 5 Nov 2015.